Collect

One 5.0 mL EDTA (Lavendar) tube. 5.0 mL of blood or 3.0 mL minimum.

Unacceptable Conditions

The specimen will be considered unacceptable if it is refrigerated, clotted, hemalyzed, centrifuged, received in the lab over 48 hours from collection, or no CBC results performed on a specimen collected the same time as the specimen for the assay.

Storage/Transport Temperature

Ambient

Stability (from collection to initiation)

Will accept up to within 48 hours if there is a CBC result performed on a specimen collected the same time as the specimen.

Performed

Flow Cytometry Laboratory.  Monday-Friday (Specimens must be received by 1100 on Friday).

Remarks

Provide CBC results performed on a specimen collected the same time as the specimen for the lymph assay.

Performed

Flow Cytometry Laboratory.  Monday-Friday (Specimens must be received by 1100 on Friday).

Reported

Monday through Friday:  Results in 24 hours

Reference Interval

  0-3 mo 3-6 mo 6-12 mo 1-2 yr 2-5 yr 6-11 yr 12-18 yr >19 year
  % /cmm % /cmm % /cmm % /cmm % /cmm % /cmm % /cmm % /cmm
CD3 53-84 2500-5500 51-77 2500-5600 49-76 1900-5900 53-75 2100-6200 56-75 1400-3700 60-76 1200-2600 56-84 1000-2200 61.0-88.6 427-3455
CD19 6-32 300-2000 11-41 430-3000 14-37 610-2600 16-35 720-2600 14-33 390-1400 13-27 270-860 6-23 70-480 3.0-25.8 21-1006
CD20 2.0-10.0% (18-310/cmm)

CPT Codes

86359,86355

Test Build Information

OrderCode OrderName ResultCode ResultName Result Units LOINC CPT
RITUX RITUXAN THERAPY PANL IWBC WHITE BLOOD COUNT   20584-9 86355, 86359
RITUX RITUXAN THERAPY PANL ILYM LYMPHOCYTES   61123-6  
RITUX RITUXAN THERAPY PANL CD3PQ CD3   20599-7  
RITUX RITUXAN THERAPY PANL CD3NQ CD3   20598-9  
RITUX RITUXAN THERAPY PANL C19PQ CD19   8117-4  
RITUX RITUXAN THERAPY PANL C19NQ CD19   8116-6  
RITUX RITUXAN THERAPY PANL CD20P CD20   20595-5  
RITUX RITUXAN THERAPY PANL CD20N CD20   9558-8  
RITUX RITUXAN THERAPY PANL TERP1 INTERPRETATION   50595-8  

Example Report

Sample Report

Additional Information

For additional information or questions, contact RPSInterfaceSupport@unmc.edu
 
Collection

Collect

One 5.0 mL EDTA (Lavendar) tube. 5.0 mL of blood or 3.0 mL minimum.

Unacceptable Conditions

The specimen will be considered unacceptable if it is refrigerated, clotted, hemalyzed, centrifuged, received in the lab over 48 hours from collection, or no CBC results performed on a specimen collected the same time as the specimen for the assay.

Storage/Transport Temperature

Ambient

Stability (from collection to initiation)

Will accept up to within 48 hours if there is a CBC result performed on a specimen collected the same time as the specimen.

Performed

Flow Cytometry Laboratory.  Monday-Friday (Specimens must be received by 1100 on Friday).

Remarks

Provide CBC results performed on a specimen collected the same time as the specimen for the lymph assay.

Ordering

Performed

Flow Cytometry Laboratory.  Monday-Friday (Specimens must be received by 1100 on Friday).

Reported

Monday through Friday:  Results in 24 hours

Result Interpretation

Reference Interval

  0-3 mo 3-6 mo 6-12 mo 1-2 yr 2-5 yr 6-11 yr 12-18 yr >19 year
  % /cmm % /cmm % /cmm % /cmm % /cmm % /cmm % /cmm % /cmm
CD3 53-84 2500-5500 51-77 2500-5600 49-76 1900-5900 53-75 2100-6200 56-75 1400-3700 60-76 1200-2600 56-84 1000-2200 61.0-88.6 427-3455
CD19 6-32 300-2000 11-41 430-3000 14-37 610-2600 16-35 720-2600 14-33 390-1400 13-27 270-860 6-23 70-480 3.0-25.8 21-1006
CD20 2.0-10.0% (18-310/cmm)
Administrative

CPT Codes

86359,86355
RPS Interface Information

Test Build Information

OrderCode OrderName ResultCode ResultName Result Units LOINC CPT
RITUX RITUXAN THERAPY PANL IWBC WHITE BLOOD COUNT   20584-9 86355, 86359
RITUX RITUXAN THERAPY PANL ILYM LYMPHOCYTES   61123-6  
RITUX RITUXAN THERAPY PANL CD3PQ CD3   20599-7  
RITUX RITUXAN THERAPY PANL CD3NQ CD3   20598-9  
RITUX RITUXAN THERAPY PANL C19PQ CD19   8117-4  
RITUX RITUXAN THERAPY PANL C19NQ CD19   8116-6  
RITUX RITUXAN THERAPY PANL CD20P CD20   20595-5  
RITUX RITUXAN THERAPY PANL CD20N CD20   9558-8  
RITUX RITUXAN THERAPY PANL TERP1 INTERPRETATION   50595-8  

Example Report

Sample Report

Additional Information

For additional information or questions, contact RPSInterfaceSupport@unmc.edu
 

×
Learn More Remind Me Later Dismiss